Hyperuricemia
Conditions
Interventions
Precision Nutrition Intervention Group:Without interfering with normal clinical diagnosis and treatment, based on the results of the subject's blood fatty acid profile, personalized supplementation wi
Control Group:Under the premise of not affecting normal clinical diagnosis and treatment, there are no other interventions except providing standard low-purine diet guidance. During the study period,
Sponsors
Chinese PLA General Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1.The selected patients should meet the following conditions: (1)Age 18–65 years; (2)Diagnosed with hyperuricemia (male serum UA >420 µmol/L, female serum UA >360 µmol/L) by a secondary or tertiary hospital, and hs-CRP >2.0 mg/L; (3)Subjects voluntarily participate in the study and sign the informed consent form; (4)Subjects can understand the content of the questionnaire and complete it independently or with the help of the investigator.
Exclusion criteria
Exclusion criteria: If the subjects have any of the following circumstances, they should be excluded from the study: (1) Renal insufficiency, active gout, severe systemic diseases, pregnant or lactating women; (2) Tendency toward violence, aggressiveness, or being a danger to themselves or others; (3) Subjects who give up midway while filling out the questionnaire and stop completing it; (4) Subjects who are unable to communicate normally with the investigator; (5) Patients who, in the opinion of the investigator, are unsuitable to participate in the study for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood fatty acid profile;The influence of precision nutritional intervention on the blood uric acid level of patients with hyperuricemia; | — |
Secondary
| Measure | Time frame |
|---|---|
| General information of patients;Patient's clinical data (blood uric acid, liver and kidney function, blood lipids, blood routine, insulin, blood glucose, hs-CRP, IL-6, sCD40L, etc.);Patient's clinical data (blood uric acid, liver and kidney function, blood lipids, blood routine, insulin, blood glucose, hs-CRP, IL-6, sCD40L, etc.);Investigate the distribution of various fatty acid proportions in the blood of patients with hyperuricemia in our country;Exploring the association between Hashimoto's hyperuricemia and fat metabolism; | — |
Countries
China
Contacts
Public ContactLiu Yinghua
Chinese PLA General Hospital
Outcome results
None listed